NON-HEPATIC HYPERAMMONEMIC COMA: A CASE REPORT

Authors

  • Chenna Keshava BG MS Ramaiah Memorial Hospital
  • Durga Rao Yadavalli Jn
  • Meenakshi Giri
  • Ratna Rao

Abstract

ABSTRACT
While the most common cause of hyperammonemic (HA) coma is hepatic disorder, other rare etiologies to be considered include congenital causes,
drug induced states, portosystemic shunts, and urinary tract infections with urea-splitting organisms. HA usually results from one of the following
three mechanisms: A relative excessive nitrogen load on a normal functioning liver via the portal circulation (e.g., parenteral nutrition in a patient
with urea cycle defect); ammonia bypassing liver (e.g., congenital vascular malformations, portal hypertension in cirrhotic patients); or from impaired
ammonia metabolism. Herein, we describe a case of HA coma secondary to an interplay of multiple psychiatric drugs mainly sodium valproate and
probably an added effect by the lithium-induced hypothyroidism/myxedema.
Keywords: Drug-induced, Hyperammonemia, Lithium, Myxedema, Valproic acid.

Downloads

Download data is not yet available.

Author Biography

Chenna Keshava BG, MS Ramaiah Memorial Hospital

Consultant Intensivist

MSR Memorial Hospital

Bangalore

References

REFERENCES

Clay AS, Hainline BE. Hyperammonemia in the ICU. Chest

;132(4):1368-78.

Fagundes SB. Valproic acid: Review. Rev Neurosci 2008;16(2):130-6.

Johannessen CU, Johannessen SI. Valproate: Past, present, and future.

CNS Drug Rev 2003;9(2):199-216.

Gugler R, von Unruh GE. Clinical pharmacokinetics of valproic acid.

Clin Pharmacokinet 1980;5(6):67-83.

Aires CC, van Cruchten A, Ijlst L, de Almeida IT, Duran M,

Wanders RJ, et al. New insights on the mechanisms of

valproate-induced hyperammonemia: Inhibition of hepatic

N-acetylglutamate synthase activity by valproyl-CoA. J Hepatol

;55(2):426-34.

Dealberto MJ. Valproate-induced hyperammonaemic encephalopathy:

Review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol

;22(6):330-7.

Kibirige D, Luzinda K, Ssekitoleko R. Spectrum of lithium

induced thyroid abnormalities: A current perspective. Thyroid Res

;6(1):3.

Ozpoyraz N, Tamam L, Kulan E. Thyroid abnormalities in

lithium-treated patients. Adv Ther 2002;19(4):176-84.

Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR,

Burman KD, et al. A diagnostic scoring system for myxedema coma.

Endocr Pract 2014;20(8):808-17.

Published

01-05-2016

How to Cite

Keshava BG, C., D. R. Yadavalli Jn, M. Giri, and R. Rao. “NON-HEPATIC HYPERAMMONEMIC COMA: A CASE REPORT”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 2-4, https://journals.innovareacademics.in/index.php/ajpcr/article/view/11230.

Issue

Section

Case Study(s)